We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YINN icon
3601
Direxion Daily FTSE China Bull 3X ETF
YINN
$763M
$2K ﹤0.01%
3
-9
-75% -$4.9K
ZYME icon
3602
Zymeworks
ZYME
$1.6B
$2K ﹤0.01%
200
-200
-50% -$1.55K
IRD
3603
Opus Genetics
IRD
$301M
$2K ﹤0.01%
+21
New +$2.26K
CSTR
3604
DELISTED
CapStar Financial Holdings, Inc
CSTR
$2K ﹤0.01%
+104
New +$1.83K
SGEN
3605
DELISTED
Seagen Inc. Common Stock
SGEN
$2K ﹤0.01%
37
-4,263
-99% -$218K
CEN
3606
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$2K ﹤0.01%
+22
New +$2.35K
CYAD
3607
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$2K ﹤0.01%
29
+9
+45% +$404
AMOV
3608
DELISTED
America Movil SAB de CV
AMOV
$2K ﹤0.01%
109
-513
-82% -$8.81K
ABMD
3609
DELISTED
Abiomed Inc
ABMD
$2K ﹤0.01%
+12
New +$1.81K
SMTS
3610
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$2K ﹤0.01%
+700
New +$1.8K
GBT
3611
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2K ﹤0.01%
67
-774
-92% -$21.8K
DRE
3612
DELISTED
Duke Realty Corp.
DRE
$2K ﹤0.01%
65
-1,995
-97% -$57.4K
CONE
3613
DELISTED
CyrusOne Inc Common Stock
CONE
$2K ﹤0.01%
+36
New +$2.15K
NNA
3614
DELISTED
Navios Maritime Acquisition Corporation
NNA
$2K ﹤0.01%
96
-764
-89% -$15.1K
CCRC
3615
DELISTED
China Customer Relations Centers, Inc
CCRC
$2K ﹤0.01%
97
-129
-57% -$2K
NPN
3616
DELISTED
Nuveen Pennsylvania Municipal Value Fund Common shares of beneficial interest
NPN
$2K ﹤0.01%
+156
New +$2.43K
NE
3617
DELISTED
Noble Corporation
NE
$2K ﹤0.01%
336
-975
-74% -$3.66K
JASN
3618
DELISTED
Jason Industries, Inc.
JASN
$2K ﹤0.01%
1,016
-4,080
-80% -$5.04K
CRR
3619
DELISTED
Carbo Ceramics Inc.
CRR
$2K ﹤0.01%
192
-8
-4% -$56
DYNC
3620
DELISTED
Vistra Energy Corp.
DYNC
$2K ﹤0.01%
26
-74
-74% -$4.76K
NAVB
3621
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$2K ﹤0.01%
287
-2,167
-88% -$18.4K
SN
3622
DELISTED
Sanchez Energy Corporation
SN
$2K ﹤0.01%
506
-94
-16% -$483
EMJ
3623
DELISTED
Eaton Vance New Jersey Municipal Bond Fund
EMJ
$2K ﹤0.01%
+146
New +$1.92K
HQCL
3624
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
$2K ﹤0.01%
+300
New +$2.33K
FSACU
3625
DELISTED
Federal Street Acquisition Corp. Unit
FSACU
$2K ﹤0.01%
+200
New +$2.04K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.